Resources
for You and Your Team
When does AI Health Software Become an FDA Regulated Medical Device? Lessons from WHOOP and UpDoc
Does adding AI to healthcare software automatically trigger FDA regulation? Not necessarily. This article examines the FDA's 2026 WHOOP closeout letter and UpDoc's 510(k) clearance to explain how the agency evaluates AI-enabled digital health products based on intended use, clinical risk, software functionality, user interface design, and validation—not simply the use of artificial intelligence. HealthTech founders, software developers, investors, and regulatory professionals will gain practical guidance on FDA General Wellness enforcement discretion, Software as a Medical Device (SaMD), AI governance, and product design strategies that can influence whether software remains a wellness product or becomes an FDA-regulated medical device.
How States Are Enforcing New AI Laws in Healthcare—and Why It Matters
States are rapidly passing new laws to regulate Artificial Intelligence (AI) in healthcare, covering everything from mental health chatbots to AI-generated patient communications. The enforcement landscape is fragmented: some states rely on high administrative fines (up to $\$15,000$ per day), others empower Medical Boards, and some even grant a private right of action for consumers. For national digital health solutions, this patchwork of risk requires immediate mapping and proactive AI governance.